AMOHI-1, NCT04480554: Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1 |
|
|
| Recruiting | 2 | 225 | US, RoW | Methadone, Buprenorphine/naloxone, Suboxone, XR-Naltrexone, Vivitrol | University of Pennsylvania, National Institute of Drug Abuse, The Wistar Institute, Institute of Applied Medicine and Epidemiology (IMEA), Ho Chi Minh City CDC | Opioid-use Disorder, HIV-1-infection, Immune Activation, Inflammation, Methadone, Buprenorphine, Naltrexone, Antiretroviral Treatment | 06/24 | 06/24 | | |
| Completed | N/A | 17 | US | Suboxone, Buprenorphine Naloxone, Truvada, Pre-Exposure Prophylaxis (PrEP), Mavyret, Hepatitis C treatment | Duke University, Center for AIDS Research (CFAR), National Institute of Allergy and Infectious Diseases (NIAID) | Opioid Use, Opioid Use Disorder, Risk Reduction, Hiv, Hepatitis C | 03/23 | 03/23 | | |
